Chemesis International Inc. Closes Second Tranche of Private Placement
Chemesis International Inc. Closes Second Tranche of Private Placement
May 21, 2020
Vancouver, BC – Chemesis International Inc. (CSE: CSI ) ( OTC: CADMF ) ( FRA: CWAA ) (the “ Company” or
“Chemesis”), announces it has closed the second tranche of a non -brokered private placement issuing an
aggregate of 1,272,500 units (each, a “ Unit”) at a price of $0.50 per Unit for gross proceeds of $636,250.00
(the “ Private Placement ”). The Private Placement is part of a larger offering of up to 6,000,000 Units (the
“Offering”). Combined with the initial tranche of 1,420,000 Units, the Company has now raised total gross
proceeds of $1,346,250.00.
Each issued Unit consisted of one common share of the Company and one common share purchase warrant
(each, a “Warrant”) with each Warrant entitling the holder thereof to purchase one additional common share
(each, a “Warrant Share”) of the Issuer at a price of $1.00 per Wa rrant Share for a period of 24 months from
their date of issue.
All securities issued pursuant to the Private Placement are subject to a statutory hold period of four months
from the date of issue, in accordance with applicable securities legislation, expiring September 21, 2020. The
proceeds from the Private Placement, and the Offering as a whole, are intended for general working capital
and to fund potential future acquisition opportunities.
On Behalf of The Board of Directors
Josh Rosenberg
President
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto
Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it ma intains a first mover advantage as it enters new
markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The
Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality
and consistency.
Chemesis has facilities in both Puerto Rico and California. The Company is positioned to win additional licenses in
highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.
Investor Relations:
1 (604) 398-3378
Forward-Looking Information: This news release contains "forward -looking information" within the meaning of applicable
securities laws relating to statements regarding the Company's business, products and future of the Company’s business, its
product offerings and plans for sales and marketing, including with respect to the Company’s expectations regarding its suppl y
and distribution arra ngements, ability to realize benefits from its recent contractual arrangements, its plans to continue to
develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company be lieves
that the expectatio ns reflected in the forward -looking information are reasonable, there can be no assurance that such
expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward -looking information. Such
forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments
to differ materially from those contemplated by these statements depending on, among other things, the risks that the
Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its
business plans as expected, including, but not limited to, in relation to executing on and maintaining its supply and distrib ution
arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain
licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend
to update any forward-looking statements or forward-looking information in this news release. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, there can be no assurance that such
expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news
release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.